LLY80.BK Eli Lilly and Company

- THB
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
0.52%
Fundamental score
-

Is LLY80.BK undervalued?

Graham number

The Graham number of Eli Lilly and Company cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Eli Lilly and Company fundamental analysis

No fundamental analysis for Eli Lilly and Company yet.

Eli Lilly and Company stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Eli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and…

Full company profile